Founded in 2004, Pharmaron is a cutting-edge, fully integrated pharmaceutical R&D service platform supporting the life science industry. The company has invested in its people and facilities and established its comprehensive service offerings throughout the pharmaceutical R&D lifecycle. With operations in China, the US and the UK staffed by more than 11,000 employees, Pharmaron has an excellent track record in delivering end-to-end R&D solutions to its partners globally and enabling them to accelerate their novel drug discovery and development process.
Pharmaron is a contract research organization (CRO).
* Synthetic, medicinal and analytical chemistry services
* Biology services
* DMPK services
* Pharmacology services
* Drug safety assessment services
* Radiochemistry and isotopically labelled metabolism services
* Chemical & pharmaceutical development services
* Clinical development services
CRO - Contract Research Organization
Discovery Process Chemistry
Radiolabelled Chemical Synthesis
in vitro Biology
in vitro Screening
in vivo Pharmacology
Animal Disease Models
ex vivo Pharmacology
in vitro ADME
in vivo PK
Drug Product Manufacturing
14C / Carbon-14 Radiosynthesis
3H / Tritium Radiosynthesis
Microdosing Phase 0
A&A Pharmachem Inc. (founded 1992) is a leading Canadian supplier and distributor of:
- Pharmaceutical ingredients and regulatory compliance solutions
- Over the Counter ingredients products and ingredients
- Nutraceutical Ingredients
- Sports Nutrition Ingredients
- Food Ingredients
In the Pharmaceutical sector we represent many active pharmaceutical ingredient (API) manufacturers from India, China, and Taiwan as well as Western and Eastern Europe.
In the past 23 years, we have developed strong relationships with manufacturers of raw materials from Europe, India, China, US, South America, Japan. We can source and provide hard to find ingredients at cost effective prices. We differentiate from others by emphasizing on professional service and quality products, and by focusing on value creation for our customers.
Our portfolio of high quality Nutraceuticals Ingredients consists of Botanical Extracts and Powders, Specialty Ingredients, Amino Acids and Derivatives, Minerals, Vitamins, Sweeteners, Proteins, Enzymes and Blends, Vitamins and Blends, Excipients, Essential and Carrier Oils. We also stock substantial quantities of Whey Protein Concentrate, Whey Protein Isolate, Creatine Monohydrate, L-Glutamine and Branched Chain Amino Acids. In addition to the products listed on our site, we can source a wide range of specialized materials and formulations through our international network of suppliers. We act as a one stop shop by providing non-ingredient sourcing solutions such as packaging items, ranging from HDPE and PET packers and jars, to liquid and powder flavours.
Our distribution network covers entire North America through a network of 8 warehouses in Quebec, Ontario, Manitoba, British Columbia, New Jersey, Denver and Chicago. Our distributed operations enable us to deliver smallest to the largest orders efficiently and cost effectively.
Active Biotech AB (publ) (NASDAQ Stockholm: ACTI) is a biotechnology company that deploys its extensive knowledge base and portfolio of compounds to develop first-in-class immunomodulatory treatments for specialist oncology and immunology indications with a high unmet medical need and significant commercial potential. Following a portfolio refocus, the business model of Active Biotech aims to advance projects to the clinical development phase and then further develop the programs internally or pursue in partnership. Active Biotech currently holds three projects in its portfolio: Naptumomab, a targeted anti-cancer immunotherapy, partnered to NeoTX Therapeutics, is in a phase Ib/II clinical program in patients with advanced solid tumors. The small molecule immunomodulators, tasquinimod and laquinimod, both having a mode of actions that includes modulation of myeloid immune cell function, are targeted towards hematological malignancies and inflammatory eye disorders, respectively. Tasquinimod, is in clinical phase Ib/IIa for treatment of multiple myeloma. Laquinimod is advancing to a clinical phase I study with a topical ophthalmic formulation, to be followed by phase II for treatment of non-infectious uveitis. Please visit www.activebiotech.com for more information.
AEMTEK is a high quality, third party laboratory that provides testing, research, training, consulting services, and sampling products for the food, environmental, water, cosmetic, supplement and nutraceutical industries.
Located in the San Francisco Bay Area, AEMTEK is the lab of choice for top food providers and industrial hygienists around the U.S. For over 18 years, AEMTEK has helped clients obtain accurate, fast and reliable analytical data by providing complete solutions to ensure food safety, water quality and environmental health.
At AEMTEK, our staff includes seasoned industry professionals and knowledgeable Ph.D. scientists to assist you with everything from simple result interpretation to the design of complex research projects. We have experience in every aspect of laboratory testing, from food chemistry and microbiology to product formulation and food processing technology. Our staff includes experts in the development of PCR-based pathogen detection and microbial identification tests. Our extensive expertise and experience in food mycology and rapid pathogen screening are unrivaled by other commercial food labs.
We are always available and ready to serve your analytical needs! For more information about what services and products AEMTEK has to offer your business, please call us at 510-979-1979 or email us at firstname.lastname@example.org.
Agere is a global leader in bioavailability enhancement and cGMP services. Our comprehensive formulation design and development capabilities leverage Agere's Quadrant 2 solubilization formulation platform. Quadrant 2 empowers formulation development to efficiently explore a broader design space. Adhering to quality by design (QbD) guidelines de-risks results to achieve your target product profile.
All client services -- from formulation through clinical trials materials manufacturing -- are customized per API and done on a fee-for-service basis.
• Formulation design and development
• Solubilization formulation expertise
• Innovative analytical technologies
• Materials science and characterization
• Computational modeling